This is best highlighted in the breast cancer field, where the proteins estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) have been well established as prospective treatment response biomarkers [7, 8]. Here, ESR1 is linked to breast cancer.